These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11036436)

  • 21. Medication use in seniors: challenges and solutions.
    Tamblyn R
    Therapie; 1996; 51(3):269-82. PubMed ID: 8881121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computerized ambulatory-care pharmacy information system for direct order entry by prescribers.
    Serpa MD; Ting J; Lee MP; Colwell B; Kolterman O
    Am J Hosp Pharm; 1990 Feb; 47(2):361-3. PubMed ID: 2309726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability and compatibility of vancomycin for administration by continuous infusion.
    Raverdy V; Ampe E; Hecq JD; Tulkens PM
    J Antimicrob Chemother; 2013 May; 68(5):1179-82. PubMed ID: 23302579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City.
    Doubova Dubova SV; Reyes-Morales H; Torres-Arreola Ldel P; Suárez-Ortega M
    BMC Health Serv Res; 2007 Sep; 7():147. PubMed ID: 17880689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current challenges in European oncology pharmacy practice.
    Hoppe-Tichy T
    J Oncol Pharm Pract; 2010 Mar; 16(1):9-18. PubMed ID: 20015932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of tools to prevent drug incompatibilities in paediatric and neonatal intensive care units.
    De Giorgi I; Guignard B; Fonzo-Christe C; Bonnabry P
    Pharm World Sci; 2010 Aug; 32(4):520-9. PubMed ID: 20556656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cimetidine hydrochloride compatibility. III: Room temperature stability in drug admixtures.
    Yuhas EM; Lofton FT; Rosenberg HA; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1981 Dec; 38(12):1919-22. PubMed ID: 7325173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Care plan for documenting pharmacist activities.
    Chase PA; Bainbridge J
    Am J Hosp Pharm; 1993 Sep; 50(9):1885-8. PubMed ID: 8135234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacy: a profession in transition or a transitory profession?
    Penna RP
    Am J Hosp Pharm; 1987 Sep; 44(9):2053-9. PubMed ID: 3674043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centralized intravenous additive services (CIVAS): the state of the art in 2010.
    Hecq JD
    Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of common drugs with acetate-containing balanced electrolyte solutions in pediatric anesthesia.
    Heiderich S; Jürgens J; Rudolf D; Dennhardt N; Echtermeyer F; Leffler A; Sümpelmann R; Lichtinghagen R; Witt L
    Paediatr Anaesth; 2016 Jun; 26(6):590-8. PubMed ID: 27012479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
    Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
    Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I.V. additives move to the pharmacy.
    Peritore SP; Rosenberg JM
    Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
    [No Abstract]   [Full Text] [Related]  

  • 35. Justification and operation of a critical-care satellite pharmacy.
    Caldwell RD; Tuck BA
    Am J Hosp Pharm; 1983 Dec; 40(12):2141-5. PubMed ID: 6660227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions.
    Williams DA; Lokich J
    Cancer Chemother Pharmacol; 1992; 31(3):171-81. PubMed ID: 1464154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit.
    Gikic M; Di Paolo ER; Pannatier A; Cotting J
    Pharm World Sci; 2000 Jun; 22(3):88-91. PubMed ID: 11028261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of clinical pharmacy services in a hematology/oncology inpatient setting.
    Delpeuch A; Leveque D; Gourieux B; Herbrecht R
    Anticancer Res; 2015 Jan; 35(1):457-60. PubMed ID: 25550587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parenteral nutrition program in a major cancer center.
    Muller RJ; Hoffman DM; Mulligan RM
    Hosp Pharm; 1981 Feb; 16(2):54-66. PubMed ID: 10309346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.